MedBright AI Appoints Trevor Vieweg as Chief Executive Officer

MedBright AI Appoints Trevor Vieweg as Chief Executive Officer
Article Date
January 4, 2024
Press Releases

VANCOUVER, British Columbia, Jan. 04, 2024 (GLOBE NEWSWIRE) -- MedBright AI Investments Inc. (the “Company” or “MedBright AI”) (CSE:MBAI, OTCQB:MBAIF, FSE:1V7) is pleased to announce that Trevor Vieweg has joined MedBright AI as Chief Executive Officer effective January 4, 2024.

Mr. Vieweg was previously Head of Product Development at Viasat (NASDAQ:VSAT) and later served as Chief Technology Officer of Sea Machines Robotics, a venture backed AI and robotics start-up. He is an investor in, and co-founder of, Limmi, an artificial intelligence platform focused on powering complex healthcare data analytics systems, a MedBright AI investment. He holds a Bachelor’s degree in mechanical & aerospace engineering from Cornell University and a Master’s degree in enterprise software architecture from the University of California, San Diego.

“Trevor brings a tremendous amount of experience and understanding of how companies commercialize AI at scale in a diverse set of markets,” said Jaime Gerber, Chairman of MedBright AI. “The combination of Trevor’s AI and commercial expertise coupled with our strong healthcare team is the perfect match for our aim of monetizing artificial intelligence investment opportunities that can change how healthcare is delivered globally.”

Mr. Vieweg adds, “I’m thrilled to be joining the Medbright AI Investments leadership team at this critical juncture in the healthcare AI revolution. Our focus is on making investments primarily in disruptive private companies that have the potential to create significant returns for our investors in this space.”

The Company would like to thank Alnoor Nathoo for his services as interim CEO. Mr. Nathoo will continue in his role as a director of the Company.

Investor Relations Agreement

The Company also announces that it has entered into an investor relations agreement (the "Agreement") dated December 28, 2023 with Outside the Box Capital Inc. ("Outside the Box"), an arm’s length party with respect to the Company. Outside the Box has agreed to provide investor relations and communications services to the Company, including social media engagement services using social media platforms such as Twitter and YouTube, in consideration for an aggregate amount of $100,000 in cash and the grant of 400,000 incentive stock options. The stock options are exercisable at $0.25 for a period of two years and vest four months after the date of grant. The term of the Agreement is for a period of six months.

Outside the Box’s business address is 2202 Green Orchard Place, Oakville ON, L6H 4V4, email:, telephone: (289)-259-4455

About MedBright AI Investments Inc.

MedBright AI Investments is a capital allocator that invests in diversified industries, including technology, and healthcare. Investments may include equity, debt, or other securities of both public and private companies and control stake acquisitions. MedBright has a focus on significant near-term and midterm high-quality opportunities with strong return potentials while maintaining commitment to governance.

MedBright AI Investments Inc.
Trevor Vieweg, Chief Executive Officer

Cautionary Statement Regarding "Forward-Looking" Information

This release includes certain statements and information that may constitute forward-looking information within the meaning of applicable Canadian securities laws. All statements in this news release, other than statements of historical facts, including statements regarding future estimates, plans, objectives, timing, assumptions or expectations of future performance, including, without limitation, the anticipated benefits of MedMatrix such as increased clinic revenue, enhanced patient satisfaction, reduced wait times and physician burnout, the Company’s goal of positively affecting healthcare management in the United States, and the Company’s plans to generate returns for its shareholders through its portfolio of investments, are forward-looking statements and contain forward-looking information. Generally, forward-looking statements and information can be identified by the use of forward-looking terminology such as “intends” or “anticipates”, or variations of such words and phrases or statements that certain actions, events or results “may”, “could”, “should” or “would” or occur.

Forward-looking statements are based on certain material assumptions and analysis made by the Company and the opinions and estimates of management as of the date of this press release, including, among other things, that MedMatrix will offer increased clinic revenue, enhanced patient satisfaction, reduced wait times and physician burnout, that the Company will have a positive impact on healthcare management in the United States, and that the Company will be able to generate returns for its shareholders. These forward-looking statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such forward-looking statements or forward-looking information. Important risks that may cause actual results to vary, include, without limitation, the risk that the use of MedMatrix will not result in increased clinic revenue, enhanced patient satisfaction, or reduced wait times and physician burnout, and the risk that the Company’s portfolio of investments will not generate returns for shareholders.

Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information. Readers are cautioned that reliance on such information may not be appropriate for other purposes. The Company does not undertake to update any forward-looking statement, forward-looking information or financial out-look that are incorporated by reference herein, except in accordance with applicable securities laws.